Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Large Drop in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 100 shares, a decrease of 75.0% from the September 15th total of 400 shares. Based on an average trading volume of 4,200 shares, the short-interest ratio is currently 0.0 days. Based on an average trading volume of 4,200 shares, the short-interest ratio is currently 0.0 days.

Institutional Trading of Fidelity Disruptive Medicine ETF

An institutional investor recently raised its position in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC increased its holdings in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 0.8% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 66,382 shares of the company’s stock after purchasing an additional 499 shares during the quarter. Jane Street Group LLC owned 3.16% of Fidelity Disruptive Medicine ETF worth $1,567,000 as of its most recent filing with the SEC.

Fidelity Disruptive Medicine ETF Stock Performance

FMED opened at $25.98 on Friday. The firm has a 50 day moving average price of $24.73 and a 200 day moving average price of $23.89. The company has a market cap of $57.16 million, a PE ratio of 41.33 and a beta of 1.01. Fidelity Disruptive Medicine ETF has a 1 year low of $20.69 and a 1 year high of $26.79.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.